|
Exploristics present the Welcome Organisation with Christmas Shoeboxes
The team at Exploristics present a Belfast homeless charity with Christmas shoeboxes, filled with basic essentials
More>> |
|
|
ERT Launches the Industrys First Multi-Language Diagnostic Platform for Respiratory Trials
Native language capabilities significantly improve site performance and clinical data quality
More>> |
|
|
Merck to Provide Provantage® End-to-End Services to Acticor Biotech SAS
Leading science and technology company announces that it will provide its Provantage services to Acticor Biotech SAS
More>> |
|
|
Data at ASH 2016 Show Strong, Lasting Efficacy of Imbruvica® (ibrutinib) Through Five Years of Treatment for Chronic Lymphocytic Leukaemia (CLL)
89% of study patients, including those with high-risk CLL, responded to therapy. Durable and improving responses also seen in longer follow-up from Phase 3 RESONATE-2 trial. This release corresponds to abstracts #2331 and #2343
More>> |
|
|
Saneca to drive R&D Initiative following €1.5 million funding
Slovaki-based CDMO pushes forward with new R&D initiatives for the manufacture of APIs
More>> |
|
|
Mission Therapeutics Appoints Colin Goddard as Chairman
Michael Moore Transitions to Deputy Chairman
More>> |
|
|
Merck Launches Parteck® MXP Excipient for Increased Solubility
Leading science and technology company announces its polyvinyl alcohol-based excipient that enhances solubility of APIs
More>> |
|
|
Wellcome Trust Centre for Human Genetics and Genomics plc first to sequence multiple human genomes using hand-held nanopore technology
Demonstrates potential for wide-scale whole-genome sequencing in humans using nanopore approaches
More>> |
|
|
Aridhia broadens European appeal with new RSRCH Health service in Netherlands
Aridhia, Vancis and MGRID announce the expansion of their partnership
More>> |
|
|
00 44 131 560 1470
|
|
www.aridhia.com/
|
|
Hobart House, 80 Hanover Street, Edinburgh, EH2 1EL
|
| |
|
Recipharm and Laccure agree commercial collaboration
Leading contract development and manufacturing organisation (CDMO) Recipharm is entering into a collaboration with Laccure AB for the commercial manufacture and delivery of Laccure® Pessary
More>> |
|
|
|
